Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2
about
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsThe Cellular Bases of Antibody Responses during Dengue Virus InfectionWest Nile Virus: biology, transmission, and human infectionAutophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralizationIs transfusion-transmitted dengue fever a potential public health threat?Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibodyAntibodies against immature virions are not a discriminating factor for dengue disease severity.Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN.Germinal center reaction following cutaneous dengue virus infection in immune-competent miceReplacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection.DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice.Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy/Eligible Saudi Blood Donors: Findings From Holy Makkah City.A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
P2860
Q24289014-5D1656F4-DDB4-4748-834B-3676DB361E50Q26700056-BFF697A5-70C4-4284-8AA0-C802B87CEF4BQ26865618-2F30C4A2-60CC-47B0-81D7-8330114B1CFEQ27468834-C3450FAB-04B0-4CB9-A0B0-6AB2F695E12DQ28085648-B198A80A-4CB4-4B70-9C8D-FD666DF17D0FQ30392050-0F0B09F3-6377-4EB7-B673-7FE783D97229Q34976206-BD8BBBE4-90E8-4DCD-AA77-943FC1775BB4Q35168403-09D7E382-99BD-4662-AF6E-3CB367A9AEC7Q35179653-54A66ADC-4392-4855-B4D1-6B9AD4F2FF17Q35535146-946980E6-DBDD-41A8-9BDF-8F9E4ABDD740Q36234359-8F535F76-CF48-47F9-94BB-EB06930467ACQ37694852-CFDAD5C7-7129-4A2B-AF17-0650D38C8AF5Q38045381-971FBB7E-7A4A-47D4-A93A-14EDB00F5AF1Q38636217-FB38E50D-9F70-4324-90B3-C76A11722FDCQ40058562-28CE60DF-3E06-4668-94C8-A1D8457420E9Q47194469-7853D0FB-4EA3-4E58-BD5A-0F1E20C83D60
P2860
Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Antibodies against the envelop ...... mature dengue virus serotype 2
@ast
Antibodies against the envelop ...... mature dengue virus serotype 2
@en
Antibodies against the envelop ...... mature dengue virus serotype 2
@nl
type
label
Antibodies against the envelop ...... mature dengue virus serotype 2
@ast
Antibodies against the envelop ...... mature dengue virus serotype 2
@en
Antibodies against the envelop ...... mature dengue virus serotype 2
@nl
prefLabel
Antibodies against the envelop ...... mature dengue virus serotype 2
@ast
Antibodies against the envelop ...... mature dengue virus serotype 2
@en
Antibodies against the envelop ...... mature dengue virus serotype 2
@nl
P2093
P2860
P50
P1433
P1476
Antibodies against the envelop ...... mature dengue virus serotype 2
@en
P2093
Jolanda M Smit
Júlia M da Silva Voorham
Nilda Vanesa Ayala Nuñez
P2860
P304
P356
10.1371/JOURNAL.PONE.0029957
P407
P50
P577
2012-03-14T00:00:00Z